Do antidepressants really work? A clinicians' guide to evaluating the evidence

Current Psychiatry Reports

Volumn 10, Issue 6, 2008, Pages 487-494

  Thase, Michael E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CLINICAL RESEARCH; DRUG EFFICACY; DRUG INDUSTRY; DRUG RESEARCH; EVIDENCE BASED MEDICINE; HAMILTON SCALE; HUMAN; INTERMETHOD COMPARISON; MAJOR DEPRESSION; METHODOLOGY; PUBLISHING; RANDOMIZATION; RELIABILITY; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC ERROR;

ANTIDEPRESSIVE AGENTS; BIAS (EPIDEMIOLOGY); DEPRESSIVE DISORDER, MAJOR; DRUG INDUSTRY; EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUPPORT AS TOPIC; TREATMENT OUTCOME;

EID: 58449090678     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-008-0078-2     Document Type: Review

References (23)

1. Leon AC: The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses. Am J Psychiatry 2007, 164: 1786-1789.
2. Turner EH, Matthews AM, Linardatos E, et al.: Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008, 358: 252-260.
3. Kirsch I, Deacon BJ, Huedo-Medina TB, et al.: Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008, 5: E45.
4. RosenthalAR: Meta-analysis: a review. Psychosom Med 1991, 53: 247-271.
5. Thase ME: Comparing the methods used to compare antidepressants. Psychopharmacol Bull 2002, 36(Suppl 1): 1-17.
6. Lieberman JA, Greenhouse J, Hamer RM, et al.: Comparing the effects of antidepressants: Consensus guidelines for evaluating quantitative review of antidepressant efficacy. Neuropsychopharmacology 2005, 30: 445-460.
7. Depression Guideline Panel: Clinical Practice Guideline Number 5. Depression in Primary Care, Volume 2: Treatment of Major Depression 93-0551. Rockville, MD: Department of Health and Human Services Agency for Health Care Policy and Research; 1993.
8. Practice guideline for major depressive disorder in adults. American Psychiatric Association. Am J Psychiatry 1993, 150(4 Suppl): 1-26.
9. Walsh BT, Seidman SN, Sysko R, Gould M: Placebo response in studies of major depression. Variable, substantial, and growing. JAMA 2002, 287: 1840-1847.
10. Zimmerman M, Chelminski I, Posternak MA: Generalizability of antidepressant efficacy trials: Differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. Am J Psychiatry 2005, 162: 1370-1372.
11. Rothman KJ, Michels KB: Sounding board. The continuing unethical use of placebo controls. N Engl J Med 1994, 331: 394-398.
12. Charney DS, Nemeroff CB, Lewis L, et al.: National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry 2002, 59: 262-270.
13. Schatzberg AF, Kraemer HC: Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression. Biol Psychiatry 2000, 47: 736-744.
14. Leon AC, Solomon DA: Toward rapproachment in the placebo control debate. A calculated compromise of power. Eval Health Prof 2003, 26: 404-414.
15. Khan A, Warner HA, Brown WA: Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. An analysis of the Food and Drug Administration database. Arch Gen Psychiatry 2000, 57: 311-317.
16. Thase ME, Pritchett YL, Ossanna MJ, et al.: Efficacy of duloxetine and selective serotonin reuptake inhibitors: Comparators as assessed by remission rates in patients with major depressive disorder. J Clin Psychopharmacol 2007, 27: 672-676.
17. Freemantle N, Anderson IM, Young P: Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis. Br J Psychiatry 2000, 177: 292-302.
18. Cohen J: Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press; 1977.
19. Kraemer HC, Kupfer DJ: Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 2006, 59: 990-996.
20. Cipriani A, Barbui C, Brambilla P, et al.: Are all antidepressants really the same? The case of fluoxetine: A systematic review. J Clin Psychiatry 2006, 67: 850-864.
21. Perkins DO, Wyatt RJ, BTrtko JJ: Penny-wise and poundfoolish: the impact of measurement error on sample size requirements in clinical trials. Biol Psychiatry 2000, 47: 762-766.
22. Müller MJ, Szegedi A: Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials. J Clin Psychopharmacol 2002, 22: 318-325.
23. Klein DF: Flawed meta-analyses comparing psychotherapy with pharmacotherapy. Am J Psychiatry 2000, 157: 1204-1211.